GI
CMRX

Gradient Investments’s Chimerix, Inc. CMRX Stock Holding History

Gradient Investments’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500
Closed -$1K – 1571
2022
Q2 		$1K Hold
500
– – ﹤0.01% 1188
2022
Q1 		$2K Hold
500
– – ﹤0.01% 1074
2021
Q4 		$3K Buy
+500
New +$3K ﹤0.01% 1040

Other funds holding CMRX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gradient Investments's CMRX Position: Q3 2022 in Review

Gradient Investments sold out of Chimerix, Inc. (CMRX) in Q3 2022, closing a stake of 500 shares — an estimated $1K sold.

Gradient Investments first reported a position in CMRX in Q4 2021 and held it in 3 quarters. The position peaked at $3K in Q4 2021. 118 funds tracked by Wall St. Rank hold CMRX as of Q3 2022.

  • Gradient Investments reported no remaining Chimerix, Inc. position as of Q3 2022 after selling out during the quarter.
  • Gradient Investments sold 500 Chimerix, Inc. shares in Q3 2022, an estimated $1K.
  • Gradient Investments first reported a position in Chimerix, Inc. in Q4 2021 and held it in 3 quarters.
  • Gradient Investments's Chimerix, Inc. position peaked at $3K in Q4 2021.
  • 118 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2022.

Based on Gradient Investments's 13F filing for Q3 2022, filed 14 Oct 2022.